The seroprevalence of SARS-CoV-2 in patients on haemodialysis

A new study reports the seroprevalence of SARS-CoV-2 antibodies among a cross-section of patients on haemodialysis and uses these data to estimate seroprevalence in the general US population. Although this study demonstrates the potential of monitoring infectious disease prevalence in dialysis popul...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahalingasivam, Viyaasan, Tomlinson, Laurie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
News & Views
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682124/
https://www.ncbi.nlm.nih.gov/pubmed/33230249
http://dx.doi.org/10.1038/s41581-020-00379-y
_version_ 1783612646333874176
author Mahalingasivam, Viyaasan
Tomlinson, Laurie
author_facet Mahalingasivam, Viyaasan
Tomlinson, Laurie
author_sort Mahalingasivam, Viyaasan
collection PubMed
description A new study reports the seroprevalence of SARS-CoV-2 antibodies among a cross-section of patients on haemodialysis and uses these data to estimate seroprevalence in the general US population. Although this study demonstrates the potential of monitoring infectious disease prevalence in dialysis populations, the findings should be interpreted with caution.
format Online
Article
Text
id pubmed-7682124
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-76821242020-11-24 The seroprevalence of SARS-CoV-2 in patients on haemodialysis Mahalingasivam, Viyaasan Tomlinson, Laurie Nat Rev Nephrol News & Views A new study reports the seroprevalence of SARS-CoV-2 antibodies among a cross-section of patients on haemodialysis and uses these data to estimate seroprevalence in the general US population. Although this study demonstrates the potential of monitoring infectious disease prevalence in dialysis populations, the findings should be interpreted with caution. Nature Publishing Group UK 2020-11-23 2021 /pmc/articles/PMC7682124/ /pubmed/33230249 http://dx.doi.org/10.1038/s41581-020-00379-y Text en © Springer Nature Limited 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle News & Views
Mahalingasivam, Viyaasan
Tomlinson, Laurie
The seroprevalence of SARS-CoV-2 in patients on haemodialysis
title The seroprevalence of SARS-CoV-2 in patients on haemodialysis
title_full The seroprevalence of SARS-CoV-2 in patients on haemodialysis
title_fullStr The seroprevalence of SARS-CoV-2 in patients on haemodialysis
title_full_unstemmed The seroprevalence of SARS-CoV-2 in patients on haemodialysis
title_short The seroprevalence of SARS-CoV-2 in patients on haemodialysis
title_sort seroprevalence of sars-cov-2 in patients on haemodialysis
topic News & Views
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682124/
https://www.ncbi.nlm.nih.gov/pubmed/33230249
http://dx.doi.org/10.1038/s41581-020-00379-y
work_keys_str_mv AT mahalingasivamviyaasan theseroprevalenceofsarscov2inpatientsonhaemodialysis
AT tomlinsonlaurie theseroprevalenceofsarscov2inpatientsonhaemodialysis
AT mahalingasivamviyaasan seroprevalenceofsarscov2inpatientsonhaemodialysis
AT tomlinsonlaurie seroprevalenceofsarscov2inpatientsonhaemodialysis

Ejemplares similares